Sigma1 and dopamine D2 receptor occupancy in the mouse brain after a single administration of haloperidol and two dopamine D2-like receptor ligands

被引:12
|
作者
Ishiwata, K
Kawamura, K
Kobayashi, T
Matsuno, K
机构
[1] Tokyo Metropolitan Inst Gerontol, Positron Med Ctr, Itabashi Ku, Tokyo 1730022, Japan
[2] SHI Accelerator Serv Co Ltd, Shinagawa Ku, Tokyo 1418686, Japan
[3] Ms Sci Co Ltd, Chuo Ku, Kobe, Hyogo 6500047, Japan
[4] Santen Pharmaceut Co Ltd, Nara Res & Dev Ctr, Ikoma 6300101, Japan
关键词
haloperidol; sigma(1) receptor; dopamine D-2 receptor; C-11]SA4503; C-11]raclopride; positron emission tomography;
D O I
10.1016/S0969-8051(03)00003-9
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
We investigated sigma, and dopamine D-2 receptor occupancy in mouse brain after a single injection of haloperidol, nemonapride, or spiperone using [C-11]SA4503 and [C-11]raclopride, respectively. Co-injection of the three compounds significantly blocked the uptake of each radioligand. Six hours later, only haloperidol blocked [C-11]SA4503 uptake, while all three reduced [C-11]raclopride uptake. Sigma(1) receptor occupancy by haloperidol was reduced to 19% at day 2 when D-2 receptor occupancy disappeared. [C-11]SA4503 would be applicable to the investigation of sigma, receptor occupancy of antispychotic drugs using PET. (C) 2003 Elsevier Inc. All rights reserved.
引用
收藏
页码:429 / 434
页数:6
相关论文
共 50 条
  • [31] EANM procedure guidelines for brain neurotransmission SPECT/PET using dopamine D2 receptor ligands, version 2
    Van Laere, Koen
    Varrone, Andrea
    Booij, Jan
    Borght, Thierry Vander
    Nobili, Flavio
    Kapucu, Oezlem L.
    Walker, Zuzana
    Nagren, Kjell
    Tatsch, Klaus
    Darcourt, Jacques
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2010, 37 (02) : 434 - 442
  • [32] Hyperprolactinemia and estimated dopamine D2 receptor occupancy in patients with schizophrenia: Analysis of the CATIE data
    Tsuboi, Takashi
    Bies, Robert R.
    Suzuki, Takefumi
    Mamo, David C.
    Pollock, Bruce G.
    Graff-Guerrero, Ariel
    Mimura, Masaru
    Uchida, Hiroyuki
    PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2013, 45 : 178 - 182
  • [33] Effects of haloperidol and GM1 ganglioside treatment on striatal D2 receptor binding and dopamine turnover
    Vital, MABF
    Florio, JC
    Frussa, R
    De Lucia, R
    Tufik, S
    Palermo-Neto, J
    LIFE SCIENCES, 1998, 62 (13) : 1161 - 1169
  • [34] Haloperidol-induced catalepsy is absent in dopamine D2 but maintained in dopamine D3 receptor knock-out mice
    Boulay, D
    Depoortere, R
    Oblin, A
    Sanger, DJ
    Schoemaker, H
    Perrault, G
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2000, 391 (1-2) : 63 - 73
  • [35] Antipsychotics, dopamine D2 receptor occupancy and clinical improvement in schizophrenia: A meta-analysis
    Yilmaz, Zeynep
    Zai, Clement C.
    Hwang, Rudi
    Mann, Steve
    Arenovich, Tamara
    Remington, Gary
    Daskalakis, Zafiris J.
    SCHIZOPHRENIA RESEARCH, 2012, 140 (1-3) : 214 - 220
  • [36] Prediction of CNS occupancy of dopamine D2 receptor based on systemic exposure and in vitro experiments
    Kanamitsu, Kayoko
    Arakawa, Ryosuke
    Sugiyama, Yuichi
    Suhara, Tetsuya
    Kusuhara, Hiroyuki
    DRUG METABOLISM AND PHARMACOKINETICS, 2016, 31 (06) : 395 - 404
  • [37] Decreased dopamine D2 receptor binding in essential blepharospasm
    Horie, C.
    Suzuki, Y.
    Kiyosawa, M.
    Mochizuki, M.
    Wakakura, M.
    Oda, K.
    Ishiwata, K.
    Ishii, K.
    ACTA NEUROLOGICA SCANDINAVICA, 2009, 119 (01): : 49 - 54
  • [38] Optimal Extent of Dopamine D2 Receptor Occupancy by Antipsychotics for Treatment of Dopamine Supersensitivity Psychosis and Late-Onset Psychosis
    Iyo, Masaomi
    Tadokoro, Shigenori
    Kanahara, Nobuhisa
    Hashimoto, Tasuku
    Niitsu, Tomihisa
    Watanabe, Hiroyuki
    Hashimoto, Kenji
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2013, 33 (03) : 398 - 404
  • [39] Dopamine Synthesis Capacity is Associated with D2/3 Receptor Binding but Not Dopamine Release
    Berry, Anne S.
    Shah, Vyoma D.
    Furman, Daniella J.
    White, Robert L., III
    Baker, Suzanne L.
    O'Neil, James P.
    Janabi, Mustafa
    D'Esposito, Mark
    Jagust, William J.
    NEUROPSYCHOPHARMACOLOGY, 2018, 43 (06) : 1201 - 1211
  • [40] D2 dopamine receptor regulation of learning, sleep and plasticity
    Franca, A. S. C.
    Lobao-Soares, B.
    Muratori, L.
    Nascimento, G.
    Winne, J.
    Pereira, C. M.
    Jeronimo, S. M. B.
    Ribeiro, S.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2015, 25 (04) : 493 - 504